PMID 14681504
Pharm Res 32 , 35263540 (2015)
Watch for: MOTS-C: mild energy changes weeks 12, more noticeable improvement by week 34 5-Amino-1MQ: subtle metabolic shift, most noticeable when combined with consistent Zone 2 cardio NAD+: gradual energy improvement, not stimulant-like Timing: Reta: once weekly subQ MOTS-C: 500mcg/day subQ, morning fasted or pre-workout NAD+ (NMN/NR): morning with food 5-Amino-1MQ: morning, fasted or with NAD+ supplement What to Realistically Expect 5-Amino-1MQ is not a dramatic compound
Progressive mitochondrial SOD1(G93A) accumulation causes severe structural, metabolic and functional aberrations through OPA1 Down-Regulation in a mouse model of amyotrophic lateral sclerosis
Buserelin A GnRH Agonist for Hormonal Reset What it does: Buserelin stimulates LH and FSH release through GnRH receptor activation, helping rebalance the HPG axis
Here, to better define this clinically taxing and translationally challenging malignancy, we applied a multiomics approach, consisting of 13 modalities to analyze 173 treatment-naive individuals with AML